$SLDB 3 SEC Filings

Filed On	Filing
24 Jun 2026	Form 3: Ra Capital MANAGEMENT, L.p., 10% owner and 3 others Holds 11,897,896 shares of Common Stock
19 Feb 2025	Form 3: Adage Capital Management, L.p., 10% owner and 2 others Holds 3,995,539 shares of Common Stock, $0.001 par value per share
19 Jan 2024	Form 3: Bcls Ii Equity Opportunities GP, Llc, Director and 1 other Holds 904,160 shares of Common Stock
20 Oct 2023	Form 3: Brooks Gabriel, Chief Medical Officer No securities owned
11 Jan 2023	Form 3: Tan Kevin, CFO & Treasurer No securities owned
05 Dec 2022	Form 3: Hanrahan Jessie, Chief Regulatory Officer No securities owned
05 Dec 2022	Form 3: Marlowe Jennifer, CSO, FA & Cardiac No securities owned
05 Dec 2022	Form 3: Howton David T, See Remarks No securities owned
05 Dec 2022	Form 3: Herzich Paul, Chief Technology Officer No securities owned
05 Dec 2022	Form 3: Cumbo Alexander, Director No securities owned
05 Dec 2022	Form 3: Koppel Adam, Director Holds 3,130,423 shares of Common Stock
05 Dec 2022	Form 3: Bain Capital Life Sciences Investors, Llc, 10% owner and 7 others Holds 3,130,423 shares of Common Stock
04 Mar 2021	Form 3: Keresty Georgia, Director No securities owned
04 Mar 2021	Form 3: Kahn Clare, Director No securities owned
03 Mar 2021	Form 3: Brennan Erin Powers, Chief Legal Officer, Secretary No securities owned
01 Feb 2021	Form 3: DiPalma Stephen J., Interim CFO
15 Dec 2020	Form 3: Ra Capital MANAGEMENT, L.p., Director and 2 others Holds 8,709,882 shares of Common Stock
30 Oct 2020	Form 3: Ultragenyx Pharmaceutical Inc., 10% owner Holds 7,825,797 shares of Common Stock
16 Apr 2020	Form 3: Smith Ian F, Director
06 Mar 2019	Form 3: Boxer Capital, Llc, 10% owner and 4 others Holds 3,923,272 shares of Common Stock

Comments